HOME >> BIOLOGY >> NEWS
Treatable psychiatric symptoms common with degenerative brain disease

Potentially treatable psychiatric problems are common in patients with degenerative brain diseases affecting movement and coordination, according to a study by Johns Hopkins scientists. Up to 80 per cent of those with either Huntington's disease or degenerative diseases affecting the cerebellum also suffer from depression, impaired thinking and changes in personality, the study found.

"Traditionally, there has been this distinction between neurological and psychiatric disorders, but it is an artificial distinction," said lead author Russell L. Margolis, M.D., associate professor of psychiatry at Hopkins and director of the Laboratory of Genetic Neurobiology.

"Indeed, the high rate of psychiatric disorders in these patients suggests that many, if not most, can benefit from treatment, even if the course of the brain disease itself cannot be reversed. Many symptoms can be eased, and the quality of life for these patients and their families can be greatly enhanced," says Margolis.

"Our findings of high rates of psychiatric disorders in Huntington's disease confirm the results of previous studies, and we believe we've found the first well-established link between serious psychiatric disorders and the cerebellum, a region at the back of the brain densely packed with nerve cells," notes Margolis.

In the study, Margolis and his colleagues conducted detailed interviews and analyzed brain images of three groups: 31 patients with degenerative cerebellar disease, 21 patients with Huntington's disease and 29 people who had no signs of brain disease. The results, reported in the August issue of the American Journal of Psychiatry, found that 77 per cent of patients with cerebellar disease had psychiatric disorders, and 81 per cent of Huntington's disease patients did so, rates nearly double those seen in healthy control subjects (41 per cent). Sixty-eight per cent of those with cerebellar disease suffered from mood disorders like depression, com
'"/>

Contact: Trent Stockton
tstockt1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
6-Aug-2002


Page: 1 2 3

Related biology news :

1. Brain serotonin enzyme finding might explain psychiatric disorders
2. Researchers caution against linking strep, neuropsychiatric disorders
3. New tool for studying animal models of neurological and psychiatric diseases
4. Environmental and genetic factors influence development of psychiatric disorder
5. Chronic respiratory symptoms prevalent among Alaska natives
6. Ritalin may improve Parkinsons symptoms, OHSU study says
7. UT Southwestern research halts narcolepsy symptoms
8. Dec. 17 JAMA study shows new biologic drug reduces psoriasis symptoms, improves quality of life
9. Imperial researchers show novel flu treatment eliminates symptoms in mice
10. Gene therapy delays death in mouse with symptoms of Lou Gehrigs disease
11. Spectrum of West Nile symptoms includes paralysis

Post Your Comments:
(Date:10/16/2014)... Syncytial Virus causes severe respiratory tract infections and ... year. Scientists at VIB and Ghent University have ... counteract this common virus infection. , Xavier ... that paves the way for the development of ... virus that causes suffering in numerous small children ...
(Date:10/15/2014)... WASHINGTON, N.Y. , Oct. 15, 2014 /PRNewswire/ ... technology solutions for home and community-based care, today ... benefits of implementing Sandata,s Santrax® Electronic Visit Verification™ ... Care Services is a home health company founded ... Texas . The ...
(Date:10/15/2014)... Gauß-Allianz has admitted Johannes Gutenberg University Mainz (JGU) ... science hub continues to maintain a significant nationwide ... , "The acceptance of Johannes Gutenberg University Mainz ... a milestone in the national and international competition ... state of Rhineland-Palatinate can be proud that Mainz ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2Sandata Announces Case Study with Quality Care Services, Inc. 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
(Date:10/22/2014)... (PRWEB) October 22, 2014 Physicians ... its cardiovascular pharmacogenetics menu, which enables healthcare providers ... With PCLS’s evidence-based results, healthcare providers are ... optimize their therapy, while minimizing risks for adverse ... U.S., according to the FDA [1] more than ...
(Date:10/22/2014)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... Oral Amphotericin B program.  The company recently announced ... work involving samples from HIV/AIDS patients exposed to ... clinical studies and regulatory filings to move forward ... approximately $700,000 of funding and technological advice from ...
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... 2014 Convey Computer , the ... from Iowa State University won first place in the ... Convey HC-2ex, the team’s solution achieved the highest overall ... the second place finisher. , Experts from all segments ... month long challenge, using a variety of design tools, ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
Cached News: